These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37326109)

  • 1. The MyD88 inhibitor, ST2825, induces cell cycle arrest and apoptosis by suppressing the activation of the NF‑κB/AKT1/p21 pathway in pancreatic cancer.
    Lu S; He T; Zhang Y; Zhou B; Zhang Q; Yan S
    Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37326109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disrupting myddosome assembly in diffuse large B‑cell lymphoma cells using the MYD88 dimerization inhibitor ST2825.
    Wang X; Tan Y; Huang Z; Huang N; Gao M; Zhou F; Hu J; Feng W
    Oncol Rep; 2019 Nov; 42(5):1755-1766. PubMed ID: 31432184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway.
    Zheng S; Hu C; Lin H; Li G; Xia R; Zhang X; Su D; Li Z; Zhou Q; Chen R
    J Exp Clin Cancer Res; 2022 Feb; 41(1):71. PubMed ID: 35189958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulated expression of IL‑28RA is involved in the pathogenesis of pancreatic ductal adenocarcinoma.
    Liu L; Qi Y; Huang D; Xu Y; Li M; Hong Z; Gu Y; Jia B; Luo X; Zhang S; Zhang S
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
    Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
    Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcinoma.
    Cheng K; Zhou Z; Chen Q; Chen Z; Cai Y; Cai H; Wu S; Gao P; Cai Y; Zhou J; Wang X; Wu Z; Peng B
    Sci Rep; 2024 Apr; 14(1):8389. PubMed ID: 38600093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MyD88 dimerization inhibitor ST2825 targets the aggressiveness of synovial fibroblasts in rheumatoid arthritis patients.
    Ramirez-Perez S; Vekariya R; Gautam S; Reyes-Perez IV; Drissi H; Bhattaram P
    Arthritis Res Ther; 2023 Sep; 25(1):180. PubMed ID: 37749630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dinaciclib exerts a tumor-suppressing effect via β-catenin/YAP axis in pancreatic ductal adenocarcinoma.
    Li Y; Zheng Z; Xiao L; Chen Y; Liu X; Long D; Chai L; Li Y; Tan C
    Anticancer Drugs; 2024 Feb; 35(2):140-154. PubMed ID: 37694833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-940 inhibited pancreatic ductal adenocarcinoma growth by targeting MyD88.
    Song B; Zhang C; Li G; Jin G; Liu C
    Cell Physiol Biochem; 2015; 35(3):1167-77. PubMed ID: 25766528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis.
    Chile T; Fortes MA; Corrêa-Giannella ML; Brentani HP; Maria DA; Puga RD; de Paula Vde J; Kubrusly MS; Novak EM; Bacchella T; Giorgi RR
    BMC Cancer; 2013 Oct; 13():451. PubMed ID: 24088503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting CDK4/6 in pancreatic ductal adenocarcinoma via microRNA-21.
    Mortoglou M; Miralles F; Mould RR; Sengupta D; Uysal-Onganer P
    Eur J Cell Biol; 2023 Jun; 102(2):151318. PubMed ID: 37105116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting MyD88: Therapeutic mechanisms and potential applications of the specific inhibitor ST2825.
    Liu M; Kang W; Hu Z; Wang C; Zhang Y
    Inflamm Res; 2023 Nov; 72(10-11):2023-2036. PubMed ID: 37814128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosmarinic Acid Decreases the Malignancy of Pancreatic Cancer Through Inhibiting Gli1 Signaling.
    Zhou X; Wang W; Li Z; Chen L; Wen C; Ruan Q; Xu Z; Liu R; Xu J; Bai Y; Deng J
    Phytomedicine; 2022 Jan; 95():153861. PubMed ID: 34864627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
    Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
    Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Seleno-Aspirinyl Compound AS-10 Induces Apoptosis, G1 Arrest of Pancreatic Ductal Adenocarcinoma Cells, Inhibits Their NF-κB Signaling, and Synergizes with Gemcitabine Cytotoxicity.
    Karelia DN; Kim S; K Pandey M; Plano D; Amin S; Lu J; Sharma AK
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TBL1XR1 induces cell proliferation and inhibit cell apoptosis by the PI3K/AKT pathway in pancreatic ductal adenocarcinoma.
    Gu JF; Fu W; Qian HX; Gu WX; Zong Y; Chen Q; Lu L
    World J Gastroenterol; 2020 Jul; 26(25):3586-3602. PubMed ID: 32742128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
    J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
    Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.
    Loiarro M; Capolunghi F; Fantò N; Gallo G; Campo S; Arseni B; Carsetti R; Carminati P; De Santis R; Ruggiero V; Sette C
    J Leukoc Biol; 2007 Oct; 82(4):801-10. PubMed ID: 17548806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.